Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ")
Recruiting now
Conditions studied: Juvenile Recurrent Respiratory Papillomatosis
In brief
Recurrent respiratory papillomatosis (RRP) is a rare disease. However, it is the most common benign laryngeal tumor in children. To date, no epidemiological data are available in France. The aim of this study is to establish the epidemiology of juvenile PPR.
Key facts
- Study ID
- NCT06000527
- Run by
- Imagine Institute
- People needed
- 200
- Starts
- 2022-10-01
- Expected to finish
- 2032-09-30
- Last updated by the study team
- 2023-08-21
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with juvenile PRR (disease onset before age 18)
- Followed in the :
- The MALO CRMR
- One of the MALO network's CCMRs
- One of the main correspondent centers
You may not qualify if…
- Patients objecting to the collection of their personal data
- Parents of minor patients objecting to the collection of their child's personal data
Where it is running
- hôpital Necker Enfants malades — Paris, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.